Afatinib/erlotinibRash and diarrhoea: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1662卷 / 1期

关键词：

D O I：

10.1007/s40278-017-33654-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：24 / 24

相关论文

共 50 条

[21] Afatinib/icotinib/osimertinibDrug resistance and diarrhoea: case report
Reactions Weekly, 2019, 1767 (1) : 25 - 25
[22] PaclitaxelAnaemia, diarrhoea, liver toxicity, and thrombocytopenia: 4 case reports
Reactions Weekly, 2014, 1513 (1) : 28 - 28
[23] Levodopa/benserazide/oxitriptanVomiting, dyskinesia and diarrhoea: 4 case reports
Reactions Weekly, 2021, 1868 (1) : 239 - 239
[24] Carboplatin/immunotherapies/paclitaxelMyelosuppression, diarrhoea and dermatitis: 4 case reports
Reactions Weekly, 2022, 1900 (1) : 97 - 97
[25] Afatinib/icotinibAcquired drug resistance, rash and diarrhoea: case report
Reactions Weekly, 2019, 1734 (1) : 23 - 23
[26] Afatinib/crizotinibMouth ulcers, diarrhoea and increased ALT: case report
Reactions Weekly, 2019, 1752 (1) : 19 - 19
[27] ErlotinibRash: case report
Reactions Weekly, 2013, 1459 (1) : 19 - 19
[28] ErlotinibRash: case report
Reactions Weekly, 2018, 1716 (1) : 130 - 130
[29] ErlotinibRash: case report
Reactions Weekly, 2015, 1549 (1) : 106 - 106
[30] Afatinib/bevacizumabAcquired resistance: 8 case reports
Reactions Weekly, 2018, 1726 (1) : 20 - 20

← 1 2 3 4 5 →